Aage Drivsholm

427 citations
23 papers · 357 indexed · h-index 12
Topics
Multiple Myeloma Research and Treatments (12 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers)Acute Myeloid Leukemia Research (3 papers)
Partner nations
DenmarkNorway

In The Last Decade

Aage Drivsholm

22 papers receiving 328 citations

Peers

Aage Drivsholm
Comparison fields: 5 of 53
  • Hematology 257
  • Molecular Biology 111
  • Genetics 101
  • Oncology 77
  • Immunology 65
Replace K Hirashima with:
K Hirashima Japan
Y Yoshida Japan
M Okabe Japan
Mauri Keinänen Finland
LD Petz United States
JH Bourhis United States
Rita Michalevicz Israel
Henriëtte M. Goselink Netherlands
Chiu-Hwa Wang Taiwan
Virendra O. Shah United States
Aage Drivsholm relative to K Hirashima Japan K Hirashima's profile →
Citations per field
00.5×
K Hirashima · 1×
Citations per year

Countries citing papers authored by Aage Drivsholm

Since Specialization
Citations

This map shows the geographic impact of Aage Drivsholm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aage Drivsholm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aage Drivsholm more than expected).

Fields of papers citing papers by Aage Drivsholm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aage Drivsholm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aage Drivsholm. The network helps show where Aage Drivsholm may publish in the future.

Co-authorship network of co-authors of Aage Drivsholm

This figure shows the co-authorship network connecting the top 25 collaborators of Aage Drivsholm. A scholar is included among the top collaborators of Aage Drivsholm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aage Drivsholm. Aage Drivsholm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 26
3 16
4 5
5 10
6 4
7 16
8 21
9 20
10 3
11 46
12 7
13 71
14 8
15 14
16 11
17 28
18 8
19 1
20 11

About Aage Drivsholm

Aage Drivsholm is a scholar working on Hematology, Genetics and Emergency Medicine, having authored 23 papers that have together received 357 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Acute Myeloid Leukemia Research (3 papers). The work is most often cited by research in Hematology (257 citations), Genetics (101 citations) and Immunology (65 citations). Aage Drivsholm has collaborated with scholars based in Denmark and Norway. Frequent co-authors include Preben Philip, Mogens Krogh Jensen, Niels Ebbe Hansen, Sven-Åge Killmann, J. B. Hertz, Henrik Birgens, F. Espersen, Sven‐Aage Killmann, Hans Jørgen Nielsen and Henrik Nielsen. Their work appears in journals such as Cancer Immunology Immunotherapy, American Journal of Hematology and Apmis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026